Alterations characteristic of GBMs were observed in nine out of ten tumour tissues (chromosome 7 gain/EGFR gene amplification n = 9, chromosome 10 loss including PTEN gene n = 8, Table S2). This evidence concerns the gene PTEN and neoplasm.